Ask AI

Podcasts

Share

Program Content

Activities

  • BTKi Therapy for CLL and MCL: ASCO 2022
    New Evidence With BTK Inhibitor Therapy in CLL and MCL From ASCO 2022
    Conference Coverage
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 06, 2022

  • BTKi Therapy for CLL and MCL: EHA 2022
    New Evidence With BTK Inhibitor Therapy in CLL and MCL From EHA 2022
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 21, 2022

  • BTKi Therapy for CLL, MCL: PPLC 2022
    New Evidence With BTK Inhibitor Therapy in CLL and MCL From the Pan Pacific Lymphoma Conference 2022
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 30, 2022

  • BTKi Therapy for CLL, MCL: SOHO 2022
    New Evidence With BTK Inhibitor Therapy in CLL and MCL From the SOHO 2022 Annual Meeting
    Conference Coverage
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 28, 2022

Provided by

ProCE Banner

Supporters

Lilly